A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo in patients with Parkinson's disease A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center s ...
A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo in patients with Parkinson's disease A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center s ...